메뉴 건너뛰기




Volumn 155, Issue 3, 2008, Pages 455-464

Post-myocardial infarction β-blocker therapy: The bradycardia conundrum. Rationale and design for the Pacemaker & β-blocker therapy post-MI (PACE-MI) trial

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; METOPROLOL SUCCINATE;

EID: 39249083147     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.041     Document Type: Article
Times cited : (10)

References (82)
  • 1
    • 0037176263 scopus 로고    scopus 로고
    • Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
    • The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288 (2002) 3115-3123
    • (2002) JAMA , vol.288 , pp. 3115-3123
    • The DAVID Trial Investigators1
  • 2
    • 0020078179 scopus 로고
    • A randomized trial of propranolol in patients with acute myocardial infarction I. Mortality results
    • Beta-Blocker Heart Attack Study Group
    • Beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction I. Mortality results. JAMA 247 (1982) 1707-1714
    • (1982) JAMA , vol.247 , pp. 1707-1714
  • 3
    • 0020059988 scopus 로고
    • One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian Multicentre Trial
    • Hansteen V., Moinichen E., Lorentsen E., et al. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian Multicentre Trial. Br Med J (Clin Res Ed) 284 (1982) 155-160
    • (1982) Br Med J (Clin Res Ed) , vol.284 , pp. 155-160
    • Hansteen, V.1    Moinichen, E.2    Lorentsen, E.3
  • 4
    • 0019520254 scopus 로고
    • Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial
    • Hjalmarson A., Herlitz J., Malek I., et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet 2 (1981) 823-827
    • (1981) Lancet , vol.2 , pp. 823-827
    • Hjalmarson, A.1    Herlitz, J.2    Malek, I.3
  • 5
    • 0022350075 scopus 로고
    • Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction
    • Pedersen T. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med 313 (1985) 1055-1058
    • (1985) N Engl J Med , vol.313 , pp. 1055-1058
    • Pedersen, T.1
  • 6
    • 0019459311 scopus 로고
    • Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
    • The Norwegian Multicenter Study Group
    • The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304 (1981) 801-807
    • (1981) N Engl J Med , vol.304 , pp. 801-807
  • 7
    • 0027491257 scopus 로고
    • Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials
    • Teo K., Yusuf S., and Furberg C. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 270 (1993) 1589-1595
    • (1993) JAMA , vol.270 , pp. 1589-1595
    • Teo, K.1    Yusuf, S.2    Furberg, C.3
  • 8
    • 0000093848 scopus 로고    scopus 로고
    • Beta blockade after myocardial infarction: systematic review and meta regression analysis
    • Freemantle N., Cleland J., Young P., et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
    • (1999) BMJ , vol.318 , pp. 1730-1737
    • Freemantle, N.1    Cleland, J.2    Young, P.3
  • 9
    • 0030896503 scopus 로고    scopus 로고
    • Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prevention Secondaire de l'Infarctus
    • Cucherat M., Boissel J.P., and Leizorovicz A. Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prevention Secondaire de l'Infarctus. Am J Cardiol 79 (1997) 87-589
    • (1997) Am J Cardiol , vol.79 , pp. 87-589
    • Cucherat, M.1    Boissel, J.P.2    Leizorovicz, A.3
  • 10
    • 0032547328 scopus 로고    scopus 로고
    • National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project
    • Krumholz H., Radford M., Wang Y., et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project. JAMA 280 (1998) 623-629
    • (1998) JAMA , vol.280 , pp. 623-629
    • Krumholz, H.1    Radford, M.2    Wang, Y.3
  • 11
    • 0032552240 scopus 로고    scopus 로고
    • Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
    • Gottlieb S., McCarter R., and Vogel R. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
    • (1998) N Engl J Med , vol.339 , pp. 489-497
    • Gottlieb, S.1    McCarter, R.2    Vogel, R.3
  • 12
    • 0031025108 scopus 로고    scopus 로고
    • Adverse outcomes of underuse of b-blockers in elderly survivors of acute myocardial infarction
    • Soumerai S., McLaughlin T., Spiegelman D., et al. Adverse outcomes of underuse of b-blockers in elderly survivors of acute myocardial infarction. JAMA 277 (1997) 115-121
    • (1997) JAMA , vol.277 , pp. 115-121
    • Soumerai, S.1    McLaughlin, T.2    Spiegelman, D.3
  • 13
    • 0031667044 scopus 로고    scopus 로고
    • Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience
    • Pfisterer M., Cox J., Granger C., et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 32 (1998) 634-640
    • (1998) J Am Coll Cardiol , vol.32 , pp. 634-640
    • Pfisterer, M.1    Cox, J.2    Granger, C.3
  • 14
    • 0037093796 scopus 로고    scopus 로고
    • Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers
    • Aronow W., and Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers. Am J Cardiol 89 (2002) 1207-1209
    • (2002) Am J Cardiol , vol.89 , pp. 1207-1209
    • Aronow, W.1    Ahn, C.2
  • 15
    • 0035581276 scopus 로고    scopus 로고
    • Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction
    • Aronow W., Ahn C., and Kronzon I. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 88 (2001) 1298-1300
    • (2001) Am J Cardiol , vol.88 , pp. 1298-1300
    • Aronow, W.1    Ahn, C.2    Kronzon, I.3
  • 16
    • 0031018677 scopus 로고    scopus 로고
    • Beta-adrenergic blocking agents or angiotensin converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction
    • O'Rourke R. Beta-adrenergic blocking agents or angiotensin converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction. J Am Coll Cardiol 29 (1997) 237-239
    • (1997) J Am Coll Cardiol , vol.29 , pp. 237-239
    • O'Rourke, R.1
  • 17
    • 0032995096 scopus 로고    scopus 로고
    • Beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study
    • Spargias K., Hall A., Greenwood D., et al. Beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study. Heart 81 (1999) 25-32
    • (1999) Heart , vol.81 , pp. 25-32
    • Spargias, K.1    Hall, A.2    Greenwood, D.3
  • 18
    • 0031033495 scopus 로고    scopus 로고
    • Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study
    • Vantrimpont P., Rouleau J., Wun C., et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. J Am Coll Cardiol 29 (1997) 229-236
    • (1997) J Am Coll Cardiol , vol.29 , pp. 229-236
    • Vantrimpont, P.1    Rouleau, J.2    Wun, C.3
  • 19
    • 0034630114 scopus 로고    scopus 로고
    • Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?
    • Chen J., Radford M., Wang Y., et al. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?. Arch Intern Med 160 (2000) 947-952
    • (2000) Arch Intern Med , vol.160 , pp. 947-952
    • Chen, J.1    Radford, M.2    Wang, Y.3
  • 20
    • 2442441133 scopus 로고    scopus 로고
    • Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    • Kernis S., Harjai K., Stone G., et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?. J Am Coll Cardiol 43 (2004) 1773-1779
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1773-1779
    • Kernis, S.1    Harjai, K.2    Stone, G.3
  • 21
    • 0035810547 scopus 로고    scopus 로고
    • Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
    • The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
    • (2001) Lancet , vol.357 , pp. 1385-1390
    • The CAPRICORN Investigators1
  • 22
    • 3843091541 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction)
    • Antman E., Anbe D., Armstrong P., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) 588-636
    • (2004) Circulation , vol.110 , pp. 588-636
    • Antman, E.1    Anbe, D.2    Armstrong, P.3
  • 23
    • 0037010012 scopus 로고    scopus 로고
    • Braunwald E, Antman E, Beasley J, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). 2002. Available at http://www.acc.org/clinical/guidelines/unstable/unstable.pdf.
    • Braunwald E, Antman E, Beasley J, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). 2002. Available at http://www.acc.org/clinical/guidelines/unstable/unstable.pdf.
  • 24
    • 0033621148 scopus 로고    scopus 로고
    • 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of acute myocardial infarction)
    • Ryan T., Antman E., Brooks N., et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of acute myocardial infarction). Circulation 100 (1999) 1016-1030
    • (1999) Circulation , vol.100 , pp. 1016-1030
    • Ryan, T.1    Antman, E.2    Brooks, N.3
  • 25
    • 33644866848 scopus 로고    scopus 로고
    • ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction)
    • Krumholz H.M., J A., Brooks N.H., et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation 113 (2006) 732-761
    • (2006) Circulation , vol.113 , pp. 732-761
    • Krumholz, H.M.1    Spertus, J.A.2    Brooks, N.H.3
  • 26
    • 0021341606 scopus 로고
    • Beta-adrenergic blockade for survivors of acute myocardial infarction
    • Frishman W., Furberg C., and Friedewald W. Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med 310 (1984) 830-837
    • (1984) N Engl J Med , vol.310 , pp. 830-837
    • Frishman, W.1    Furberg, C.2    Friedewald, W.3
  • 27
    • 0026501035 scopus 로고
    • Metoprolol-induced reduction in mortality: pooled results from five double-blind randomized trials
    • Olsson G., Wikstrand J., Warnold I., et al. Metoprolol-induced reduction in mortality: pooled results from five double-blind randomized trials. Eur Heart J 13 (1992) 28-32
    • (1992) Eur Heart J , vol.13 , pp. 28-32
    • Olsson, G.1    Wikstrand, J.2    Warnold, I.3
  • 28
    • 0021909115 scopus 로고
    • Beta blockade during and after myocardial infarction: an overview of the randomized trials
    • Yusuf S., Peto R., Lewis J., et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335-371
    • (1985) Prog Cardiovasc Dis , vol.27 , pp. 335-371
    • Yusuf, S.1    Peto, R.2    Lewis, J.3
  • 29
    • 0022541191 scopus 로고
    • Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
    • Kjekshus J. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57 (1986) 43F-49F
    • (1986) Am J Cardiol , vol.57
    • Kjekshus, J.1
  • 30
    • 0022505487 scopus 로고
    • Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest
    • Gundersen T., Grottum P., Pedersen T., et al. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 58 (1986) 20-24
    • (1986) Am J Cardiol , vol.58 , pp. 20-24
    • Gundersen, T.1    Grottum, P.2    Pedersen, T.3
  • 31
    • 0025308219 scopus 로고
    • Influence of heart rate on mortality after myocardial infarction
    • Hjalmarson A., Gilpin E., Kjekshus J., et al. Influence of heart rate on mortality after myocardial infarction. Am J Cardiol 65 (1990) 547-553
    • (1990) Am J Cardiol , vol.65 , pp. 547-553
    • Hjalmarson, A.1    Gilpin, E.2    Kjekshus, J.3
  • 32
    • 0034690671 scopus 로고    scopus 로고
    • Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomized placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)
    • Boden W., vanGilst W., Scheldewaert R., et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomized placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Lancet 355 (2000) 1751-1756
    • (2000) Lancet , vol.355 , pp. 1751-1756
    • Boden, W.1    vanGilst, W.2    Scheldewaert, R.3
  • 33
    • 0025052399 scopus 로고
    • Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II)
    • for the Danish Study Group on Verapamilin Myocardial Infarction
    • Hansen J., and for the Danish Study Group on Verapamilin Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 66 (1990) 779-785
    • (1990) Am J Cardiol , vol.66 , pp. 779-785
    • Hansen, J.1
  • 34
    • 0023713599 scopus 로고
    • The effect of diltiazem on mortality and reinfarction after myocardial infarction
    • The Multicenter Diltiazem Postinfarction Trial Research Group
    • The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319 (1988) 385-392
    • (1988) N Engl J Med , vol.319 , pp. 385-392
  • 35
    • 0031029373 scopus 로고    scopus 로고
    • Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
    • Cairns J., Connolly S., Roberts R., et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349 (1997) 675-682
    • (1997) Lancet , vol.349 , pp. 675-682
    • Cairns, J.1    Connolly, S.2    Roberts, R.3
  • 36
    • 0031038213 scopus 로고    scopus 로고
    • Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
    • Julian D., Camm A., Frangin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349 (1997) 667-674
    • (1997) Lancet , vol.349 , pp. 667-674
    • Julian, D.1    Camm, A.2    Frangin, G.3
  • 37
    • 0035901588 scopus 로고    scopus 로고
    • Treatment of patients with myocardial infarction who present with a paced rhythm
    • Rathore S., Weinfurt K., Gersh B., et al. Treatment of patients with myocardial infarction who present with a paced rhythm. Ann Intern Med 134 (2001) 644-651
    • (2001) Ann Intern Med , vol.134 , pp. 644-651
    • Rathore, S.1    Weinfurt, K.2    Gersh, B.3
  • 38
    • 0035853053 scopus 로고    scopus 로고
    • Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial
    • Lechat P., Hulot J., Escolano S., et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 103 (2001) 1428-1433
    • (2001) Circulation , vol.103 , pp. 1428-1433
    • Lechat, P.1    Hulot, J.2    Escolano, S.3
  • 39
    • 19944429041 scopus 로고    scopus 로고
    • What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?
    • Gullestad L., Wikstrand J., Deedwania P., et al. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?. J Am Coll Cardiol 45 (2005) 252-259
    • (2005) J Am Coll Cardiol , vol.45 , pp. 252-259
    • Gullestad, L.1    Wikstrand, J.2    Deedwania, P.3
  • 40
    • 0032498720 scopus 로고    scopus 로고
    • Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization
    • Barron H., Viskin S., Lundstrom R., et al. Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization. Arch Intern Med 158 (1998) 449-453
    • (1998) Arch Intern Med , vol.158 , pp. 449-453
    • Barron, H.1    Viskin, S.2    Lundstrom, R.3
  • 41
    • 0343090401 scopus 로고    scopus 로고
    • Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction
    • Rochon P., Tu J., Anderson G., et al. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 356 (2000) 639-644
    • (2000) Lancet , vol.356 , pp. 639-644
    • Rochon, P.1    Tu, J.2    Anderson, G.3
  • 42
    • 0030699497 scopus 로고    scopus 로고
    • Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period
    • Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 80 Suppl (1997) 35J-39J
    • (1997) Am J Cardiol , vol.80 , Issue.SUPPL
    • Hjalmarson, A.1
  • 43
    • 0022255627 scopus 로고
    • Initiating events of sudden cardiac death
    • Panidis I., and Morganroth J. Initiating events of sudden cardiac death. Cardiovasc Clin 15 (1985) 81-92
    • (1985) Cardiovasc Clin , vol.15 , pp. 81-92
    • Panidis, I.1    Morganroth, J.2
  • 44
    • 0020676547 scopus 로고
    • Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold
    • Anderson J., Rodier H., and Green L. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol 51 (1983) 1196-1202
    • (1983) Am J Cardiol , vol.51 , pp. 1196-1202
    • Anderson, J.1    Rodier, H.2    Green, L.3
  • 45
    • 0030610120 scopus 로고    scopus 로고
    • Beta-2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta-2-adrenergic stimulation in animals susceptible to sudden death
    • Billman G., Castillo L., Hensley J., et al. Beta-2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta-2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96 (1997) 1914-1922
    • (1997) Circulation , vol.96 , pp. 1914-1922
    • Billman, G.1    Castillo, L.2    Hensley, J.3
  • 46
    • 0032701152 scopus 로고    scopus 로고
    • Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial
    • Exner D., Reiffel J., Epstein A., et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol 34 (1999) 325-333
    • (1999) J Am Coll Cardiol , vol.34 , pp. 325-333
    • Exner, D.1    Reiffel, J.2    Epstein, A.3
  • 47
    • 0025934221 scopus 로고
    • An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985
    • Hallstrom A., Cobb L., Yu B., et al. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 68 (1991) 1025-1031
    • (1991) Am J Cardiol , vol.68 , pp. 1025-1031
    • Hallstrom, A.1    Cobb, L.2    Yu, B.3
  • 48
    • 0030861425 scopus 로고    scopus 로고
    • Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine?
    • Avanzini F., Zuanetti G., Latini R., et al. Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine?. Eur Heart J 18 (1997) 1447-1456
    • (1997) Eur Heart J , vol.18 , pp. 1447-1456
    • Avanzini, F.1    Zuanetti, G.2    Latini, R.3
  • 49
    • 0028856179 scopus 로고
    • Cardiologists' practices compared with practice guidelines: use of beta-blockage after acute myocardial infarction
    • Brand D., Newcomer L., Freiburger A., et al. Cardiologists' practices compared with practice guidelines: use of beta-blockage after acute myocardial infarction. J Am Coll Cardiol 26 (1995) 1432-1436
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1432-1436
    • Brand, D.1    Newcomer, L.2    Freiburger, A.3
  • 50
    • 0033611478 scopus 로고    scopus 로고
    • Do "America's best hospitals" perform better for acute myocardial infarction
    • Chen J., Radford M., Wang Y., et al. Do "America's best hospitals" perform better for acute myocardial infarction. N Engl J Med 340 (1999) 286-292
    • (1999) N Engl J Med , vol.340 , pp. 286-292
    • Chen, J.1    Radford, M.2    Wang, Y.3
  • 51
    • 0029782457 scopus 로고    scopus 로고
    • Hospital care and survival of acute myocardial infarction patients in Minnesota and southern Germany: a comparative study
    • Shahar E., Lewis M., Keil U., et al. Hospital care and survival of acute myocardial infarction patients in Minnesota and southern Germany: a comparative study. Coron Artery Dis 7 (1996) 467-473
    • (1996) Coron Artery Dis , vol.7 , pp. 467-473
    • Shahar, E.1    Lewis, M.2    Keil, U.3
  • 52
    • 0028965782 scopus 로고
    • Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice
    • Viskin S., Kitzis I., Lev E., et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 25 (1995) 1327-1332
    • (1995) J Am Coll Cardiol , vol.25 , pp. 1327-1332
    • Viskin, S.1    Kitzis, I.2    Lev, E.3
  • 53
    • 0033586001 scopus 로고    scopus 로고
    • How should age affect management of acute myocardial infarction? A prospective cohort study
    • Barakat K., Wilkinson P., Deaner A., et al. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 353 (1999) 955-959
    • (1999) Lancet , vol.353 , pp. 955-959
    • Barakat, K.1    Wilkinson, P.2    Deaner, A.3
  • 54
    • 0032915839 scopus 로고    scopus 로고
    • Management and outcome of acute myocardial infarction in older patients in the thrombolytic era
    • Mahon N., Codd M., O'Rorke C., et al. Management and outcome of acute myocardial infarction in older patients in the thrombolytic era. J Am Geriatr Soc 47 (1999) 291-294
    • (1999) J Am Geriatr Soc , vol.47 , pp. 291-294
    • Mahon, N.1    Codd, M.2    O'Rorke, C.3
  • 55
    • 0030698261 scopus 로고    scopus 로고
    • Underutilization of beta-blockers in older patients with prior myocardial infarction or coronary artery disease in an academic, hospital-based geriatrics practice
    • Mendelson G., and Aronow W. Underutilization of beta-blockers in older patients with prior myocardial infarction or coronary artery disease in an academic, hospital-based geriatrics practice. J Am Geriatr Soc 45 (1997) 1360-1361
    • (1997) J Am Geriatr Soc , vol.45 , pp. 1360-1361
    • Mendelson, G.1    Aronow, W.2
  • 56
    • 0021839784 scopus 로고
    • Metroprolol in acute myocardial infarction (MIAMI): a randomized placebo-controlled international trial
    • The MIAMI Trial Research Group
    • The MIAMI Trial Research Group. Metroprolol in acute myocardial infarction (MIAMI): a randomized placebo-controlled international trial. Eur Heart J 6 (1985) 199-226
    • (1985) Eur Heart J , vol.6 , pp. 199-226
  • 57
    • 0026099412 scopus 로고
    • Immediate versus deferred beta blockade following thrombolysis in myocardial infarction
    • Roberts R., Roberts W., and Mueller H. Immediate versus deferred beta blockade following thrombolysis in myocardial infarction. Circulation 83 (1991) 422-437
    • (1991) Circulation , vol.83 , pp. 422-437
    • Roberts, R.1    Roberts, W.2    Mueller, H.3
  • 58
    • 0033662123 scopus 로고    scopus 로고
    • Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the national registry of myocardial infarction 1, 2 and 3
    • Rogers W., Canto J., Lambrew C., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the national registry of myocardial infarction 1, 2 and 3. J Am Coll Cardiol 36 (2000) 2056-2063
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2056-2063
    • Rogers, W.1    Canto, J.2    Lambrew, C.3
  • 59
    • 0032942280 scopus 로고    scopus 로고
    • Patterns of practice for acute myocardial infarction in a population from ten countries
    • Venturini F., Romero M., and Tognoni G. Patterns of practice for acute myocardial infarction in a population from ten countries. Eur J Clin Pharmacol 54 (1999) 877-886
    • (1999) Eur J Clin Pharmacol , vol.54 , pp. 877-886
    • Venturini, F.1    Romero, M.2    Tognoni, G.3
  • 60
    • 0033820021 scopus 로고    scopus 로고
    • Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction
    • Heller D., Ahern F., and Kozak M. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction. Am Heart J 140 (2000) 663-671
    • (2000) Am Heart J , vol.140 , pp. 663-671
    • Heller, D.1    Ahern, F.2    Kozak, M.3
  • 61
    • 0034921641 scopus 로고    scopus 로고
    • Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population
    • Fehrenbach S., Budnitz D., Gazmararian J., et al. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population. Am J Manag Care 7 (2001) 717-723
    • (2001) Am J Manag Care , vol.7 , pp. 717-723
    • Fehrenbach, S.1    Budnitz, D.2    Gazmararian, J.3
  • 62
    • 0034614172 scopus 로고    scopus 로고
    • Health and economic benefits of increased beta-blocker use following myocardial infarction
    • Phillips K., Shlipak M., Coxson P., et al. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA 284 (2000) 2748-2754
    • (2000) JAMA , vol.284 , pp. 2748-2754
    • Phillips, K.1    Shlipak, M.2    Coxson, P.3
  • 63
    • 10244242679 scopus 로고    scopus 로고
    • Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries Trial
    • White H., Barbash G., Califf R., et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries Trial. Circulation 94 (1996) 1826-1833
    • (1996) Circulation , vol.94 , pp. 1826-1833
    • White, H.1    Barbash, G.2    Califf, R.3
  • 64
    • 0030784513 scopus 로고    scopus 로고
    • Postinfarction use of beta-blockers in elderly patients
    • Aronow W. Postinfarction use of beta-blockers in elderly patients. Drugs Aging 11 (1997) 424-432
    • (1997) Drugs Aging , vol.11 , pp. 424-432
    • Aronow, W.1
  • 65
    • 0020372727 scopus 로고
    • Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction
    • The Norwegian Multicenter Study Group
    • The Norwegian Multicenter Study Group. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Circulation 66 (1982) 1179-1184
    • (1982) Circulation , vol.66 , pp. 1179-1184
  • 66
    • 0029957182 scopus 로고    scopus 로고
    • Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy
    • Hoffman J., Grimm W., Menz V., et al. Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 19 11 Pt 2 (1996) 1841-1844
    • (1996) Pacing Clin Electrophysiol , vol.19 , Issue.11 PART 2 , pp. 1841-1844
    • Hoffman, J.1    Grimm, W.2    Menz, V.3
  • 67
    • 0013922381 scopus 로고
    • Cardiac hemodynamics during stimulation of the right atrium, right ventricle, and left ventricle in normal and abnormal hearts
    • Benchimol A., and Liggett M. Cardiac hemodynamics during stimulation of the right atrium, right ventricle, and left ventricle in normal and abnormal hearts. Circulation 33 (1966) 933-944
    • (1966) Circulation , vol.33 , pp. 933-944
    • Benchimol, A.1    Liggett, M.2
  • 68
    • 0016681353 scopus 로고
    • Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment
    • Bengtsson C., Johnsson G., and Regardh C. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment. Clin Pharmacol Ther 17 (1975) 400-408
    • (1975) Clin Pharmacol Ther , vol.17 , pp. 400-408
    • Bengtsson, C.1    Johnsson, G.2    Regardh, C.3
  • 69
    • 0022227776 scopus 로고
    • Comparative effects of adimolol, labetalol, and propranolol on heart rate and blood pressure in man
    • Riddell J., Harron D., and Shanks R. Comparative effects of adimolol, labetalol, and propranolol on heart rate and blood pressure in man. Br J Clin Pharmacol 19 (1985) 405-410
    • (1985) Br J Clin Pharmacol , vol.19 , pp. 405-410
    • Riddell, J.1    Harron, D.2    Shanks, R.3
  • 70
    • 0022642465 scopus 로고
    • Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man
    • Thomas M., and Tattersfield A. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man. Eur J Clin Pharmacol 29 (1986) 679-683
    • (1986) Eur J Clin Pharmacol , vol.29 , pp. 679-683
    • Thomas, M.1    Tattersfield, A.2
  • 71
    • 0014610966 scopus 로고
    • The effects of propranolol on cardiac conduction
    • Berkowitz W., Wit A., Lau S., et al. The effects of propranolol on cardiac conduction. Circulation 40 (1969) 855-862
    • (1969) Circulation , vol.40 , pp. 855-862
    • Berkowitz, W.1    Wit, A.2    Lau, S.3
  • 72
    • 0015155091 scopus 로고
    • Use of bundle of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents
    • Smithen C., Balcon R., and Sowton E. Use of bundle of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents. Br Heart J 33 (1971) 955-961
    • (1971) Br Heart J , vol.33 , pp. 955-961
    • Smithen, C.1    Balcon, R.2    Sowton, E.3
  • 73
    • 0015902048 scopus 로고
    • Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program
    • Greenblatt D., and Koch-Weser J. Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. Am Heart J 86 (1973) 478-484
    • (1973) Am Heart J , vol.86 , pp. 478-484
    • Greenblatt, D.1    Koch-Weser, J.2
  • 74
    • 0016366622 scopus 로고
    • Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston Collaborative Drug Surveillance Program
    • Greenblatt D., and Koch-Weser J. Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston Collaborative Drug Surveillance Program. Drugs 7 (1974) 118-129
    • (1974) Drugs , vol.7 , pp. 118-129
    • Greenblatt, D.1    Koch-Weser, J.2
  • 75
    • 0029014059 scopus 로고
    • Management of the postmyocardial infarction patient: a consensus report-revision of 1991 CCS Guidelines
    • Fallen E., Cairns J., Dafoe W., et al. Management of the postmyocardial infarction patient: a consensus report-revision of 1991 CCS Guidelines. Can J Cardiol 11 (1995) 477-486
    • (1995) Can J Cardiol , vol.11 , pp. 477-486
    • Fallen, E.1    Cairns, J.2    Dafoe, W.3
  • 76
    • 0025046117 scopus 로고
    • Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction)
    • Gunnar R., Bourdillon P., Dixon D., et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). J Am Coll Cardiol 16 (1990) 249-292
    • (1990) J Am Coll Cardiol , vol.16 , pp. 249-292
    • Gunnar, R.1    Bourdillon, P.2    Dixon, D.3
  • 77
  • 78
    • 0032082605 scopus 로고    scopus 로고
    • Complications of dual chamber pacemaker implantation in the elderly
    • Link M., Estes N., Griffin J., et al. Complications of dual chamber pacemaker implantation in the elderly. J Interv Card Electrophysiol 2 (1998) 175-179
    • (1998) J Interv Card Electrophysiol , vol.2 , pp. 175-179
    • Link, M.1    Estes, N.2    Griffin, J.3
  • 79
    • 0037149716 scopus 로고    scopus 로고
    • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    • Moss A., Zareba W., Hall W., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
    • (2002) N Engl J Med , vol.346 , pp. 877-883
    • Moss, A.1    Zareba, W.2    Hall, W.3
  • 80
    • 0036642521 scopus 로고    scopus 로고
    • Frequency and associations of symptomatic deterioration after dual-chamber defibrillator implantation in patients with ischemic or idiopathic dilated cardiomyopathy
    • Saad E., Marrouche N., Martin D., et al. Frequency and associations of symptomatic deterioration after dual-chamber defibrillator implantation in patients with ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 90 (2002) 79-82
    • (2002) Am J Cardiol , vol.90 , pp. 79-82
    • Saad, E.1    Marrouche, N.2    Martin, D.3
  • 81
    • 22744443121 scopus 로고    scopus 로고
    • Percent right ventricular pacing predicts outcomes in the DAVID trial
    • Sharma A.D., Rizo-Patron C., Hallstrom A.P., et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2 (2005) 830-834
    • (2005) Heart Rhythm , vol.2 , pp. 830-834
    • Sharma, A.D.1    Rizo-Patron, C.2    Hallstrom, A.P.3
  • 82
    • 0035810143 scopus 로고    scopus 로고
    • Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation
    • Ozcan C., Janhangir A., Friedman P., et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 344 (2001) 1043-1051
    • (2001) N Engl J Med , vol.344 , pp. 1043-1051
    • Ozcan, C.1    Janhangir, A.2    Friedman, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.